peoplePerson
Christopher R. Flowers
Christopher Flowers is a lymphoma specialist who leads MD Anderson's entire medical oncology division.
Hematologist-oncologist focused on lymphoma epidemiology, outcomes, and disparities, and on trials of novel agents in DLBCL and follicular lymphoma. Heads the Division of Cancer Medicine, the largest medical oncology group in the world.
Role
Division Head, Cancer Medicine; Chair, Lymphoma and Myeloma, MD Anderson
Institution
Specialisms
LymphomaHealth outcomesClinical trials
| Title | Journal | Year |
|---|---|---|
| Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Journal of Clinical Oncology | 2020 |
| Improving outcomes for patients with diffuse large B-cell lymphoma | CA: a Cancer Journal for Clinicians | 2010 |
Pages like this
not linked directly; found by shared links- IdeaNon-viral CAR-T (transposon or CRISPR knock-in) as the default manufacturing route
Shares CD19, Diffuse large B-cell lymphoma.
- PersonRonald Levy
Shares CD20, Diffuse large B-cell lymphoma.
- CompanyMorphoSys (Novartis)
Shares CD19, Diffuse large B-cell lymphoma.
- CompanyNkarta
Shares CD19, Diffuse large B-cell lymphoma.
- IdeaPlan the second CAR-T target before the first one is lost
Shares CD20, CD19, Diffuse large B-cell lymphoma.
- ProductOdronextamab
Shares CD20, Diffuse large B-cell lymphoma.
- CompanyInterius BioTherapeutics
Shares CD20, Diffuse large B-cell lymphoma.
- CompanyCaribou Biosciences
Shares CD19, Diffuse large B-cell lymphoma.